Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
CA 2363131 A1 · Owner: Synphora Ab · Inventors: Resul, Bahram; Stjernschantz, Johan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method comprising the use of a prostaglandin of subtype A or J for the prevention of scar formation in the filtration bleb and drainage fistula after glaucoma surgery is described. Compositions containing a prostaglandin of subtype A or J can be used topically on the eye, either as ointments or drug inserts for various time periods after , surgery to avoid fibroblast activity and proliferation in the filtration bleb end drainage fistula.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 23, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 23, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 23, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.